Moderna, Merck breakthrough could usher in wave of cancer vaccines - Reuters

Moderna and Merck have achieved a significant breakthrough that could lead to a new wave of cancer vaccines. This collaborative advancement marks a pivotal moment in oncology treatment, potentially transforming how tumors are targeted. The development involves the combined expertise of Moderna, based in Cambridge, Mass., and Merck & Co, headquartered in Rahway, N.J. This innovation signals a major shift toward personalized vaccine therapies designed to combat various forms of cancer more effectively.